{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T10:01:25Z","timestamp":1775210485312,"version":"3.50.1"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s40478-016-0294-7","type":"journal-article","created":{"date-parts":[[2016,3,8]],"date-time":"2016-03-08T06:56:22Z","timestamp":1457420182000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Deposition of C-terminally truncated A\u03b2 species A\u03b237 and A\u03b239 in Alzheimer\u2019s disease and transgenic mouse models"],"prefix":"10.1186","volume":"4","author":[{"given":"Jochim","family":"Reinert","sequence":"first","affiliation":[]},{"given":"Bernhard C.","family":"Richard","sequence":"additional","affiliation":[]},{"given":"Hans W.","family":"Klafki","sequence":"additional","affiliation":[]},{"given":"Beate","family":"Friedrich","sequence":"additional","affiliation":[]},{"given":"Thomas A.","family":"Bayer","sequence":"additional","affiliation":[]},{"given":"Jens","family":"Wiltfang","sequence":"additional","affiliation":[]},{"given":"Gabor G.","family":"Kovacs","sequence":"additional","affiliation":[]},{"given":"Martin","family":"Ingelsson","sequence":"additional","affiliation":[]},{"given":"Lars","family":"Lannfelt","sequence":"additional","affiliation":[]},{"given":"Anders","family":"Paetau","sequence":"additional","affiliation":[]},{"given":"Jonas","family":"Bergquist","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4115-0334","authenticated-orcid":false,"given":"Oliver","family":"Wirths","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2016,3,8]]},"reference":[{"key":"294_CR1","doi-asserted-by":"crossref","first-page":"10272","DOI":"10.1021\/bi00032a022","volume":"34","author":"A Asami-Odaka","year":"1995","unstructured":"Asami-Odaka A, Ishibashi Y, Kikuchi T, Kitada C, Suzuki N. Long amyloid beta-protein secreted from wild-type human neuroblastoma IMR-32 cells. Biochemistry. 1995;34:10272\u20138.","journal-title":"Biochemistry"},{"key":"294_CR2","doi-asserted-by":"crossref","unstructured":"Bansal S, Maurya IK, Yadav N, Thota CK, Kumar V, Tikoo K, Chauhan VS, Jain R. C-Terminal Fragment, Abeta, Analogues Protect Against Abeta Aggregation-Induced Toxicity. ACS Chem Neurosci. 2016. doi: 10.1021\/acschemneuro.6b00006 .","DOI":"10.1021\/acschemneuro.6b00006"},{"key":"294_CR3","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1046\/j.1471-4159.2002.00985.x","volume":"82","author":"D Beher","year":"2002","unstructured":"Beher D, Wrigley JD, Owens AP, Shearman MS. Generation of C-terminally truncated amyloid-beta peptides is dependent on gamma-secretase activity. J Neurochem. 2002;82:563\u201375.","journal-title":"J Neurochem"},{"key":"294_CR4","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1111\/j.1471-4159.2005.03578.x","volume":"96","author":"M Bentahir","year":"2006","unstructured":"Bentahir M, Nyabi O, Verhamme J, Tolia A, Horr\u00e9 K, Wiltfang J, Esselmann H, De Strooper B. Presenilin clinical mutations can affect \u03b3-secretase activity by different mechanisms. J Neurochem. 2006;96:732\u201342. doi: 10.1111\/j.1471-4159.2005.03578.x .","journal-title":"J Neurochem"},{"key":"294_CR5","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/S0002-9440(10)63388-3","volume":"165","author":"C Casas","year":"2004","unstructured":"Casas C, Sergeant N, Itier JM, Blanchard V, Wirths O, van der Kolk N, Vingtdeux V, van de Steeg E, Ret G, Canton T, et al. Massive CA1\/2 neuronal loss with intraneuronal and N-terminal truncated Abeta42 accumulation in a novel Alzheimer transgenic model. Am J Pathol. 2004;165:1289\u2013300. doi: 10.1016\/S0002-9440(10)63388-3 .","journal-title":"Am J Pathol"},{"key":"294_CR6","doi-asserted-by":"crossref","unstructured":"Chen W, Gamache E, Rosenman DJ, Xie J, Lopez MM, Li Y-M, Wang C. Familial Alzheimer\u2019s mutations within APPTM increase A\u03b242 production by enhancing accessibility of \u03b5-cleavage site. Nat Commun. 2014;5. doi: 10.1038\/ncomms4037 .","DOI":"10.1038\/ncomms4037"},{"key":"294_CR7","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0301-0082(99)00033-7","volume":"60","author":"C Czech","year":"2000","unstructured":"Czech C, Tremp G, Pradier L. Presenilins and Alzheimer\u2019s disease: biological functions and pathogenic mechanisms. Prog Neurobiol. 2000;60:363\u201384.","journal-title":"Prog Neurobiol"},{"key":"294_CR8","doi-asserted-by":"crossref","first-page":"17049","DOI":"10.1074\/jbc.M802912200","volume":"283","author":"E Czirr","year":"2008","unstructured":"Czirr E, Cottrell BA, Leuchtenberger S, Kukar T, Ladd TB, Esselmann H, Paul S, Schubenel R, Torpey JW, Pietrzik CU, et al. Independent generation of Abeta42 and Abeta38 peptide species by gamma-secretase. J Biol Chem. 2008;283:17049\u201354. doi: 10.1074\/jbc.M802912200 .","journal-title":"J Biol Chem"},{"key":"294_CR9","doi-asserted-by":"crossref","first-page":"13532","DOI":"10.1021\/bi049399k","volume":"43","author":"S Funamoto","year":"2004","unstructured":"Funamoto S, Morishima-Kawashima M, Tanimura Y, Hirotani N, Saido TC, Ihara Y. Truncated carboxyl-terminal fragments of \u03b2-amyloid precursor protein are processed to amyloid \u03b2-proteins 40 and 42\u2020. Biochemistry. 2004;43:13532\u201340. doi: 10.1021\/bi049399k .","journal-title":"Biochemistry"},{"key":"294_CR10","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/373523a0","volume":"373","author":"D Games","year":"1995","unstructured":"Games D, Adams D, Alessandrini R, Barbour R, Berthelette P, Blackwell C, Carr T, Clemens J, Donaldson T, Gillespie F, et al. Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein. Nature. 1995;373:523\u20137.","journal-title":"Nature"},{"key":"294_CR11","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.nbd.2006.08.017","volume":"24","author":"M Garcia-Alloza","year":"2006","unstructured":"Garcia-Alloza M, Robbins EM, Zhang-Nunes SX, Purcell SM, Betensky RA, Raju S, Prada C, Greenberg SM, Bacskai BJ, Frosch MP. Characterization of amyloid deposition in the APPswe\/PS1dE9 mouse model of Alzheimer disease. Neurobiol Dis. 2006;24:516\u201324.","journal-title":"Neurobiol Dis"},{"key":"294_CR12","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1016\/j.bbamem.2013.06.005","volume":"1828","author":"TE Golde","year":"2013","unstructured":"Golde TE, Koo EH, Felsenstein KM, Osborne BA, Miele L. gamma-Secretase inhibitors and modulators. Biochim Biophys Acta. 2013;1828:2898\u2013907. doi: 10.1016\/j.bbamem.2013.06.005 .","journal-title":"Biochim Biophys Acta"},{"key":"294_CR13","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1097\/00005072-198611000-00004","volume":"45","author":"PD Gorevic","year":"1986","unstructured":"Gorevic PD, Goni F, Pons-Estel B, Alvarez F, Peress NS, Frangione B. Isolation and partial characterization of neurofibrillary tangles and amyloid plaque core in Alzheimer\u2019s disease: immunohistological studies. J Neuropathol Exp Neurol. 1986;45:647\u201364.","journal-title":"J Neuropathol Exp Neurol"},{"key":"294_CR14","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/NEN.0b013e3181c6b84d","volume":"69","author":"C Guardia-Laguarta","year":"2010","unstructured":"Guardia-Laguarta C, Pera M, Clarimon J, Molinuevo JL, Sanchez-Valle R, Llado A, Coma M, Gomez-Isla T, Blesa R, Ferrer I, et al. Clinical, neuropathologic, and biochemical profile of the amyloid precursor protein I716F mutation. J Neuropathol Exp Neurol. 2010;69:53\u20139. doi: 10.1097\/NEN.0b013e3181c6b84d .","journal-title":"J Neuropathol Exp Neurol"},{"key":"294_CR15","doi-asserted-by":"crossref","first-page":"a006270","DOI":"10.1101\/cshperspect.a006270","volume":"2","author":"C Haass","year":"2012","unstructured":"Haass C, Kaether C, Thinakaran G, Sisodia S. Trafficking and proteolytic processing of APP. Cold Spring Harb Perspect Med. 2012;2:a006270. doi: 10.1101\/cshperspect.a006270 .","journal-title":"Cold Spring Harb Perspect Med"},{"key":"294_CR16","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nrm2101","volume":"8","author":"C Haass","year":"2007","unstructured":"Haass C, Selkoe DJ. Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer\u2019s amyloid [beta]-peptide. Nat Rev Mol Cell Biol. 2007;8:101\u201312.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"294_CR17","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","volume":"297","author":"J Hardy","year":"2002","unstructured":"Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer\u2019s disease: progress and problems on the road to therapeutics. Science. 2002;297:353\u20136.","journal-title":"Science"},{"key":"294_CR18","doi-asserted-by":"crossref","first-page":"8142","DOI":"10.1021\/ac401055y","volume":"85","author":"U Hau\u00dfmann","year":"2013","unstructured":"Hau\u00dfmann U, Jahn O, Linning P, Jan\u00dfen C, Liepold T, Portelius E, Zetterberg H, Bauer C, Schuchhardt J, Kn\u00f6lker H-J, et al. Analysis of amino-terminal variants of amyloid-\u03b2 peptides by capillary isoelectric focusing immunoassay. Anal Chem. 2013;85:8142\u20139. doi: 10.1021\/ac401055y .","journal-title":"Anal Chem"},{"key":"294_CR19","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.mcn.2009.02.008","volume":"41","author":"L Herl","year":"2009","unstructured":"Herl L, Thomas AV, Lill CM, Banks M, Deng A, Jones PB, Spoelgen R, Hyman BT, Berezovska O. Mutations in amyloid precursor protein affect its interactions with presenilin\/\u03b3-secretase. Mol Cell Neurosci. 2009;41:166\u201374. doi: 10.1016\/j.mcn.2009.02.008 .","journal-title":"Mol Cell Neurosci"},{"key":"294_CR20","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1750-1326-9-52","volume":"9","author":"X Hu","year":"2014","unstructured":"Hu X, Li X, Zhao M, Gottesdiener A, Luo W, Paul S. Tau pathogenesis is promoted by Abeta1-42 but not Abeta1-40. Mol Neurodegener. 2014;9:52. doi: 10.1186\/1750-1326-9-52 .","journal-title":"Mol Neurodegener"},{"key":"294_CR21","doi-asserted-by":"crossref","first-page":"22908","DOI":"10.1074\/jbc.271.37.22908","volume":"271","author":"N Ida","year":"1996","unstructured":"Ida N, Hartmann T, Pantel J, Schroder J, Zerfass R, Forstl H, Sandbrink R, Masters CL, Beyreuther K. Analysis of heterogeneous A4 peptides in human cerebrospinal fluid and blood by a newly developed sensitive Western blot assay. J Biol Chem. 1996;271:22908\u201314.","journal-title":"J Biol Chem"},{"key":"294_CR22","doi-asserted-by":"crossref","first-page":"4693","DOI":"10.1021\/bi00069a001","volume":"32","author":"JT Jarrett","year":"1993","unstructured":"Jarrett JT, Berger EP, Lansbury Jr PT. The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer\u2019s disease. Biochemistry. 1993;32:4693\u20137.","journal-title":"Biochemistry"},{"key":"294_CR23","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/2051-5960-1-60","volume":"1","author":"H Kalimo","year":"2013","unstructured":"Kalimo H, Lalowski M, Bogdanovic N, Philipson O, Bird T, Nochlin D, Schellenberg G, Brundin R, Olofsson T, Soliymani R, et al. The arctic AbetaPP mutation leads to Alzheimer\u2019s disease pathology with highly variable topographic deposition of differentially truncated Abeta. Acta Neuropathol Commun. 2013;1:60.","journal-title":"Acta Neuropathol Commun"},{"key":"294_CR24","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1523\/JNEUROSCI.4849-06.2007","volume":"27","author":"J Kim","year":"2007","unstructured":"Kim J, Onstead L, Randle S, Price R, Smithson L, Zwizinski C, Dickson DW, Golde T, McGowan E. Abeta40 inhibits amyloid deposition in vivo. J Neurosci. 2007;27:627\u201333. doi: 10.1523\/JNEUROSCI.4849-06.2007 .","journal-title":"J Neurosci"},{"key":"294_CR25","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.1038\/emboj.2010.211","volume":"29","author":"I Kuperstein","year":"2010","unstructured":"Kuperstein I, Broersen K, Benilova I, Rozenski J, Jonckheere W, Debulpaep M, Vandersteen A, Segers-Nolten I, Van Der Werf K, Subramaniam V, et al. Neurotoxicity of Alzheimer\u2019s disease Abeta peptides is induced by small changes in the Abeta42 to Abeta40 ratio. EMBO J. 2010;29:3408\u201320. doi: 10.1038\/emboj.2010.211 .","journal-title":"EMBO J"},{"key":"294_CR26","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.1073\/pnas.96.6.3053","volume":"96","author":"SF Lichtenthaler","year":"1999","unstructured":"Lichtenthaler SF, Wang R, Grimm H, Uljon SN, Masters CL, Beyreuther K. Mechanism of the cleavage specificity of Alzheimer\u2019s disease gamma-secretase identified by phenylalanine-scanning mutagenesis of the transmembrane domain of the amyloid precursor protein. Proc Natl Acad Sci U S A. 1999;96:3053\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"294_CR27","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.1002\/pmic.200700311","volume":"7","author":"JM Maler","year":"2007","unstructured":"Maler JM, Klafki H-W, Paul S, Spitzer P, Groemer TW, Henkel AW, Esselmann H, Lewczuk P, Kornhuber J, Wiltfang J. Urea-based two-dimensional electrophoresis of beta-amyloid peptides in human plasma: Evidence for novel A\u03b2 species. Proteomics. 2007;7:3815\u201320. doi: 10.1002\/pmic.200700311 .","journal-title":"Proteomics"},{"key":"294_CR28","doi-asserted-by":"crossref","first-page":"4245","DOI":"10.1073\/pnas.82.12.4245","volume":"82","author":"CL Masters","year":"1985","unstructured":"Masters CL, Simms G, Weinman NA, Multhaup G, McDonald BL, Beyreuther K. Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc Natl Acad Sci U S A. 1985;82:4245\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"294_CR29","doi-asserted-by":"crossref","first-page":"5109","DOI":"10.1074\/jbc.M113.510131","volume":"289","author":"N Matsumura","year":"2014","unstructured":"Matsumura N, Takami M, Okochi M, Wada-Kakuda S, Fujiwara H, Tagami S, Funamoto S, Ihara Y, Morishima-Kawashima M. \u03b3-Secretase associated with lipid rafts: multiple interactive pathways in the stepwise processing of \u03b2-carboxyl-terminal fragment. J Biol Chem. 2014;289:5109\u201321. doi: 10.1074\/jbc.M113.510131 .","journal-title":"J Biol Chem"},{"key":"294_CR30","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1006\/abbi.1993.1112","volume":"301","author":"DL Miller","year":"1993","unstructured":"Miller DL, Papayannopoulos IA, Styles J, Bobin SA, Lin YY, Biemann K, Iqbal K. Peptide compositions of the cerebrovascular and senile plaque core amyloid deposits of Alzheimer\u2019s disease. Arch Biochem Biophys. 1993;301:41\u201352. doi: 10.1006\/abbi.1993.1112 .","journal-title":"Arch Biochem Biophys"},{"key":"294_CR31","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/alzrt121","volume":"4","author":"BD Moore","year":"2012","unstructured":"Moore BD, Chakrabarty P, Levites Y, Kukar TL, Baine AM, Moroni T, Ladd TB, Das P, Dickson DW, Golde TE. Overlapping profiles of abeta peptides in the Alzheimer\u2019s disease and pathological aging brains. Alzheimers Res Ther. 2012;4:18. doi: 10.1186\/alzrt121 .","journal-title":"Alzheimers Res Ther"},{"key":"294_CR32","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s00401-012-1061-x","volume":"124","author":"ML Moro","year":"2012","unstructured":"Moro ML, Giaccone G, Lombardi R, Indaco A, Uggetti A, Morbin M, Saccucci S, Di Fede G, Catania M, Walsh DM, et al. APP mutations in the Abeta coding region are associated with abundant cerebral deposition of Abeta38. Acta Neuropathol. 2012;124:809\u201321. doi: 10.1007\/s00401-012-1061-x .","journal-title":"Acta Neuropathol"},{"key":"294_CR33","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/ng0892-345","volume":"1","author":"M Mullan","year":"1992","unstructured":"Mullan M, Crawford F, Axelman K, Houlden H, Lilius L, Winblad B, Lannfelt L. A pathogenic mutation for probable Alzheimer\u2019s disease in the APP gene at the N-terminus of beta-amyloid. Nat Genet. 1992;1:345\u20137. doi: 10.1038\/ng0892-345 .","journal-title":"Nat Genet"},{"key":"294_CR34","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1038\/nn0901-887","volume":"4","author":"C Nilsberth","year":"2001","unstructured":"Nilsberth C, Westlind-Danielsson A, Eckman CB, Condron MM, Axelman K, Forsell C, Stenh C, Luthman J, Teplow DB, Younkin SG, et al. The \u2018Arctic\u2019 APP mutation (E693G) causes Alzheimer\u2019s disease by enhanced Abeta protofibril formation. Nat Neurosci. 2001;4:887\u201393.","journal-title":"Nat Neurosci"},{"key":"294_CR35","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1146\/annurev-neuro-061010-113613","volume":"34","author":"RJ O'Brien","year":"2011","unstructured":"O'Brien RJ, Wong PC. Amyloid precursor protein processing and Alzheimer\u2019s disease. Annu Rev Neurosci. 2011;34:185\u2013204. doi: 10.1146\/annurev-neuro-061010-113613 .","journal-title":"Annu Rev Neurosci"},{"key":"294_CR36","doi-asserted-by":"crossref","first-page":"10129","DOI":"10.1523\/JNEUROSCI.1202-06.2006","volume":"26","author":"H Oakley","year":"2006","unstructured":"Oakley H, Cole SL, Logan S, Maus E, Shao P, Craft J, Guillozet-Bongaarts A, Ohno M, Disterhoft J, Van Eldik L, et al. Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer\u2019s disease mutations: potential factors in amyloid plaque formation. J Neurosci. 2006;26:10129\u201340.","journal-title":"J Neurosci"},{"key":"294_CR37","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0896-6273(03)00434-3","volume":"39","author":"S Oddo","year":"2003","unstructured":"Oddo S, Caccamo A, Shepherd JD, Murphy MP, Golde TE, Kayed R, Metherate R, Mattson MP, Akbari Y, LaFerla FM. Triple-transgenic model of Alzheimer\u2019s disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron. 2003;39:409\u201321.","journal-title":"Neuron"},{"key":"294_CR38","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1074\/jbc.M113.498246","volume":"289","author":"F Olsson","year":"2014","unstructured":"Olsson F, Schmidt S, Althoff V, Munter LM, Jin S, Rosqvist S, Lendahl U, Multhaup G, Lundkvist J. Characterization of intermediate steps in amyloid beta (A\u03b2) production under near-native conditions. J Biol Chem. 2014;289:1540\u201350. doi: 10.1074\/jbc.M113.498246 .","journal-title":"J Biol Chem"},{"key":"294_CR39","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1074\/jbc.M708754200","volume":"283","author":"RM Page","year":"2008","unstructured":"Page RM, Baumann K, Tomioka M, Perez-Revuelta BI, Fukumori A, Jacobsen H, Flohr A, Luebbers T, Ozmen L, Steiner H, et al. Generation of Abeta38 and Abeta42 is independently and differentially affected by familial Alzheimer disease-associated presenilin mutations and gamma-secretase modulation. J Biol Chem. 2008;283:677\u201383. doi: 10.1074\/jbc.M708754200 .","journal-title":"J Biol Chem"},{"key":"294_CR40","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1750-1326-5-2","volume":"5","author":"E Portelius","year":"2010","unstructured":"Portelius E, Andreasson U, Ringman J, Buerger K, Daborg J, Buchhave P, Hansson O, Harmsen A, Gustavsson M, Hanse E, et al. Distinct cerebrospinal fluid amyloid beta peptide signatures in sporadic and PSEN1 A431E-associated familial Alzheimer\u2019s disease. Mol Neurodegener. 2010;5:2. doi: 10.1186\/1750-1326-5-2 .","journal-title":"Mol Neurodegener"},{"key":"294_CR41","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s00401-010-0690-1","volume":"120","author":"E Portelius","year":"2010","unstructured":"Portelius E, Bogdanovic N, Gustavsson MK, Volkmann I, Brinkmalm G, Zetterberg H, Winblad B, Blennow K. Mass spectrometric characterization of brain amyloid beta isoform signatures in familial and sporadic Alzheimer\u2019s disease. Acta Neuropathol. 2010;120:185\u201393. doi: 10.1007\/s00401-010-0690-1 .","journal-title":"Acta Neuropathol"},{"key":"294_CR42","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1111\/j.1471-4159.1988.tb01087.x","volume":"51","author":"F Prelli","year":"1988","unstructured":"Prelli F, Castano E, Glenner GG, Frangione B. Differences between vascular and plaque core amyloid in Alzheimer\u2019s disease. J Neurochem. 1988;51:648\u201351. doi: 10.1111\/j.1471-4159.1988.tb01087.x .","journal-title":"J Neurochem"},{"key":"294_CR43","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1523\/JNEUROSCI.1575-04.2005","volume":"25","author":"Y Qi-Takahara","year":"2005","unstructured":"Qi-Takahara Y, Morishima-Kawashima M, Tanimura Y, Dolios G, Hirotani N, Horikoshi Y, Kametani F, Maeda M, Saido TC, Wang R, et al. Longer forms of amyloid beta protein: implications for the mechanism of intramembrane cleavage by gamma-secretase. J Neurosci. 2005;25:436\u201345.","journal-title":"J Neurosci"},{"key":"294_CR44","doi-asserted-by":"crossref","first-page":"871","DOI":"10.3233\/JAD-131373","volume":"39","author":"J Reinert","year":"2014","unstructured":"Reinert J, Martens H, Huettenrauch M, Kolbow T, Lannfelt L, Ingelsson M, Paetau A, Verkkoniemi-Ahola A, Bayer TA, Wirths O. Abeta38 in the brains of patients with sporadic and familial Alzheimer\u2019s disease and transgenic mouse models. J Alzheimers Dis. 2014;39:871\u201381. doi: 10.3233\/jad-131373 .","journal-title":"J Alzheimers Dis"},{"key":"294_CR45","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3233\/JAD-150394","volume":"49","author":"A Savastano","year":"2015","unstructured":"Savastano A, Klafki H, Haussmann U, Oberstein TJ, Muller P, Wirths O, Wiltfang J, Bayer TA. N-truncated abeta 2-X starting with position two in sporadic Alzheimer\u2019s disease cases and two Alzheimer mouse models. J Alzheimers Dis. 2015;49:101\u201310. doi: 10.3233\/jad-150349 .","journal-title":"J Alzheimers Dis"},{"key":"294_CR46","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3233\/JAD-141524","volume":"44","author":"E Sieczkowski","year":"2015","unstructured":"Sieczkowski E, Milenkovic I, Venkataramani V, Giera R, Strobel T, Hoftberger R, Liberski PP, Auff E, Wirths O, Bayer TA, et al. I716F AbetaPP mutation associates with the deposition of oligomeric pyroglutamate amyloid-beta and alpha-synucleinopathy with Lewy bodies. J Alzheimers Dis. 2015;44:103\u201314. doi: 10.3233\/jad-141524 .","journal-title":"J Alzheimers Dis"},{"key":"294_CR47","doi-asserted-by":"crossref","first-page":"813","DOI":"10.3233\/JAD-141986","volume":"45","author":"H Struyfs","year":"2015","unstructured":"Struyfs H, Van Broeck B, Timmers M, Fransen E, Sleegers K, Van Broeckhoven C, De Deyn PP, Streffer JR, Mercken M, Engelborghs S. Diagnostic accuracy of cerebrospinal fluid amyloid-beta isoforms for early and differential dementia diagnosis. J Alzheimers Dis. 2015;45:813\u201322. doi: 10.3233\/jad-141986 .","journal-title":"J Alzheimers Dis"},{"key":"294_CR48","doi-asserted-by":"crossref","first-page":"13287","DOI":"10.1073\/pnas.94.24.13287","volume":"94","author":"C Sturchler-Pierrat","year":"1997","unstructured":"Sturchler-Pierrat C, Abramowski D, Duke M, Wiederhold KH, Mistl C, Rothacher S, Ledermann B, Burki K, Frey P, Paganetti PA, et al. Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology. Proc Natl Acad Sci U S A. 1997;94:13287\u201392.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"294_CR49","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/jnc.12466","volume":"128","author":"M Su\u00e1rez-Calvet","year":"2014","unstructured":"Su\u00e1rez-Calvet M, Belbin O, Pera M, Badiola N, Magran\u00e9 J, Guardia-Laguarta C, Mu\u00f1oz L, Colom-Cadena M, Clarim\u00f3n J, Lle\u00f3 A. Autosomal-dominant Alzheimer\u2019s disease mutations at the same codon of amyloid precursor protein differentially alter A\u03b2 production. J Neurochem. 2014;128:330\u20139. doi: 10.1111\/jnc.12466 .","journal-title":"J Neurochem"},{"key":"294_CR50","doi-asserted-by":"crossref","unstructured":"Tanzi RE. The genetics of Alzheimer disease. Cold Spring Harb Perspect Med. 2012;2. doi: 10.1101\/cshperspect.a006296 .","DOI":"10.1101\/cshperspect.a006296"},{"key":"294_CR51","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1016\/S0140-6736(03)13555-6","volume":"361","author":"S Tsubuki","year":"2003","unstructured":"Tsubuki S, Takaki Y, Saido TC. Dutch, Flemish, Italian, and Arctic mutations of APP and resistance of Abeta to physiologically relevant proteolytic degradation. Lancet. 2003;361:1957\u20138. doi: 10.1016\/S0140-6736(03)13555-6 .","journal-title":"Lancet"},{"key":"294_CR52","doi-asserted-by":"crossref","first-page":"4088","DOI":"10.1016\/j.febslet.2012.10.022","volume":"586","author":"A Vandersteen","year":"2012","unstructured":"Vandersteen A, Hubin E, Sarroukh R, De Baets G, Schymkowitz J, Rousseau F, Subramaniam V, Raussens V, Wenschuh H, Wildemann D, et al. A comparative analysis of the aggregation behavior of amyloid-\u03b2 peptide variants. FEBS Lett. 2012;586:4088\u201393. doi: 10.1016\/j.febslet.2012.10.022 .","journal-title":"FEBS Lett"},{"key":"294_CR53","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1093\/jnen\/60.5.483","volume":"60","author":"A Verkkoniemi","year":"2001","unstructured":"Verkkoniemi A, Kalimo H, Paetau A, Somer M, Iwatsubo T, Hardy J, Haltia M. Variant Alzheimer disease with spastic paraparesis: neuropathological phenotype. J Neuropathol Exp Neurol. 2001;60:483\u201392. doi: 10.1093\/jnen\/60.5.483 .","journal-title":"J Neuropathol Exp Neurol"},{"key":"294_CR54","doi-asserted-by":"crossref","first-page":"31831","DOI":"10.1074\/jbc.M303592200","volume":"278","author":"S Weggen","year":"2003","unstructured":"Weggen S, Eriksen JL, Sagi SA, Pietrzik CU, Ozols V, Fauq A, Golde TE, Koo EH. Evidence that nonsteroidal anti-inflammatory drugs decrease amyloid beta 42 production by direct modulation of gamma-secretase activity. J Biol Chem. 2003;278:31831\u20137. doi: 10.1074\/jbc.M303592200 .","journal-title":"J Biol Chem"},{"key":"294_CR55","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1046\/j.1471-4159.2002.00818.x","volume":"81","author":"J Wiltfang","year":"2002","unstructured":"Wiltfang J, Esselmann H, Bibl M, Smirnov A, Otto M, Paul S, Schmidt B, Klafki HW, Maler M, Dyrks T, et al. Highly conserved and disease-specific patterns of carboxyterminally truncated Abeta peptides 1-37\/38\/39 in addition to 1-40\/42 in Alzheimer\u2019s disease and in patients with chronic neuroinflammation. J Neurochem. 2002;81:481\u201396. doi: 10.1046\/j.1471-4159.2002.00818.x .","journal-title":"J Neurochem"},{"key":"294_CR56","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1002\/elps.1150180332","volume":"18","author":"J Wiltfang","year":"1997","unstructured":"Wiltfang J, Smirnov A, Schnierstein B, Kelemen G, Matthies U, Klafki HW, Staufenbiel M, Huther G, Ruther E, Kornhuber J. Improved electrophoretic separation and immunoblotting of beta-amyloid (A beta) peptides 1-40, 1-42, and 1-43. Electrophoresis. 1997;18:527\u201332. doi: 10.1002\/elps.1150180332 .","journal-title":"Electrophoresis"},{"key":"294_CR57","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1750-3639.2002.tb00442.x","volume":"12","author":"O Wirths","year":"2002","unstructured":"Wirths O, Multhaup G, Czech C, Feldmann N, Blanchard V, Tremp G, Beyreuther K, Pradier L, Bayer TA. Intraneuronal APP\/A beta trafficking and plaque formation in beta-amyloid precursor protein and presenilin-1 transgenic mice. Brain Pathol. 2002;12:275\u201386. doi: 10.1111\/j.1750-3639.2002.tb00442.x .","journal-title":"Brain Pathol"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-016-0294-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,5]],"date-time":"2019-09-05T05:39:12Z","timestamp":1567661952000},"score":1,"resource":{"primary":{"URL":"http:\/\/actaneurocomms.biomedcentral.com\/articles\/10.1186\/s40478-016-0294-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,8]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["294"],"URL":"https:\/\/doi.org\/10.1186\/s40478-016-0294-7","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,8]]},"article-number":"24"}}